ASHWINI SAXENA: Open Payments
NPI 1972999316 · MANCHESTER, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$283 in 13 payments from 4 companies in 2025. Trend: 2023 $89 · 2024 $121 · 2025 $283
Food & beverage: $283
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 7 | $177 |
| Neurocrine BioSciences, Inc. | 3 | $55 |
| Lundbeck LLC | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: FANAPT, INGREZZA, REXULTI, TRINTELLIX.
Industry payments across NH — which companies pay providers there.
